Leisure Products

Solo Brands

Disney

Conference Minutes

01913

SBDS

CVAC

The following are the minutes of the 4Q25FY earnings call for $Disney(DIS.US) compiled by Dolphin Research. For a review of the earnings report, please refer to the article &#34;Disney: Short-term Pressure but Guidance Unchanged, Can Iger Turn the Tide Before Leaving?&#34;1. Review of Core Financial Information1. DTC Net User Growth Rebounds Beyond Expectations: Streaming user growth continued to rebound in the fourth quarter, with Disney+ adding 4 million net new users (bundled packages) and Hulu adding 8.6 million (driven by the resumption of the Charter partnership and global brand expansion), both exceeding market expectations. The growth was mainly driven by high-quality content...

PRADA

Dayforce

Ashland

Citigroup

CureVac BV

Dominion Energy

NextDecade

Ameriprise Financial

PAR Tech

Disney (Minutes): Committed to double-digit percentage growth in earnings next year

Solo Brands released FY2025 Q1 earnings on May 12 Pre-Market (EST), actual revenue USD 77.25 M (forecast USD 84 M), actual EPS USD -8.2677 (forecast USD -4.8)

Canadian Investment Bank Downgrades Solo Brands Rating to Hold, Target Price Adjusted to $1.00

Solo Brands released FY2024 earnings on March 12 Pre-Market (EST), actual revenue USD 454.55 M (forecast USD 474.07 M), actual EPS USD -77.657 (forecast USD -48)

Solo Brands released FY2024 Q4 earnings on March 12 Pre-Market (EST), actual revenue USD 143.54 M (forecast USD 161.6 M), actual EPS USD -25.2231 (forecast USD 4.4)

Solo Brands to Release FY2024 Q4 Earnings on March 12, Pre-Market EST; Forecast Revenue 161.6 M USD, EPS 0.11 USD

Solo Brands released FY2024 Q3 earnings on November 7 Pre-Market EST, actual revenue USD 94.14 M (forecast USD 92.61 M), actual EPS USD -47.7335 (forecast USD -2.5333)

Solo Brands released FY2024 9 Months earnings on November 7 Pre-Market (EST), actual revenue USD 311.01 M, actual EPS USD -52.2118

Solo Brands to Release FY2024 Q3 Earnings on November 7, Pre-Market EST; Forecasted Revenue: 92.61M USD, EPS: -0.0633 USD

Solo Brands released FY2024 Q2 earnings on August 7 Pre-Market EST, actual revenue USD 131.55 M (forecast USD 128.5 M), actual EPS USD -2.1348 (forecast USD 1.0666)

Solo Brands released FY2024 Semi-Annual earnings on August 7 Pre-Market (EST), actual revenue USD 216.87 M, actual EPS USD -4.4778

Solo Brands announces Q2 2024 financial performance

Solo Brands Inc expects a 1.8% decrease in quarterly revenue

Solo Brands released FY2024 Q1 earnings on May 9 Pre-Market (EST), actual revenue USD 85.32 M (forecast USD 78 M), actual EPS USD -2.3434 (forecast USD -4.1333)

Solo Brands released FY2023 Q4 earnings on March 14 Pre-Market (EST), actual revenue USD 165.32 M (forecast USD 166.15 M), actual EPS USD -85.5692 (forecast USD 0.8)

Solo Brands released FY2023 earnings on March 14 Pre-Market (EST), actual revenue USD 494.78 M (forecast USD 495.49 M), actual EPS USD -73.6166 (forecast USD 9.0666)

Stock price of Solo Brands falls after brokerage firms lower expectations

Solo Brands released FY2023 9 Months Earnings on November 7, Pre-Market EST: Actual Revenue USD 329.46 M, Actual EPS USD 7.8677

Solo Brands released FY2023 Q3 earnings on November 7 Pre-Market (EST), actual revenue USD 110.32 M (forecast USD 103.62 M), actual EPS USD 2.8 (forecast USD 0.1333)

Solo Brands released FY2023 Q2 earnings on August 3 Pre-Market (EST), actual revenue USD 130.93 M (forecast USD 131.64 M), actual EPS USD 4.6677 (forecast USD 3.2)

Solo Brands released FY2023 Semi-Annual earnings on August 3 Pre-Market (EST), actual revenue USD 219.13 M, actual EPS USD 5.2

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

QVCGA

MAMO

PMNT

ZSPC

QVCAQ

In Thursday's trading session, Solo Brands Inc (NYSE:SBDS) saw a significant gain of 73.1%, reaching $6.25. Other notable gainers included Massimo (NASDAQ:MAMO) up 32.77%, ZSPACE (NASDAQ:ZSPC) up 29.63%, and Perfect Moment (AMEX:PMNT) up 18.06%. Conversely, QVC Group (NASDAQ:QVCGA) experienced a sharp decline of 67.0% to $0.84 following its Q4 earnings release. Allbirds (NASDAQ:BIRD) fell 29.97%, while Vision Marine Techs (NASDAQ:VMAR) and Super X AI Technology (NASDAQ:SUPX) also saw declines of 18.4% and 11.61%, respectively.

benzinga_article

Massimo

Perfect Moment

Zspace

SPDR FD Consumer Discretionary

QVC GROUP INC

Polaris

Traeger

Allbirds

Vision Marine Tech

SuperX AI Tech

Hooker Furnishings

Lifetime Brands

Solo Brands, Inc.

SOLO BRANDS INC

QVC Pref Share QVCC 6.25 11/26/68

Qurate Retail Pref Share QRTEP 8 03/15/31

QVC Inc Pref Share QVCD 6.375 09/13/67

Qurate Retail

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

Solo Brands, Inc. (NYSE:DTC) held its Q4 2025 earnings call on March 19, 2026. The call was conducted in a listen-only mode, with an opportunity for participants to ask questions following the presentation. The transcript provides insights into the company's financial results for the fourth quarter and the full year of 2025.

Solo Brands, Inc. (NYSE:DTC) Q4 2025 earnings call transcript

LABU

ARKG

Defence Therapeutics Inc. will showcase its Accum® platform at major international events in March 2026, including BIO-Europe Spring and DCAT Week, focusing on strategic partnerships and biomanufacturing capabilities. The company aims to enhance the intracellular delivery of antibody-drug conjugates and other biologics. Additionally, Defence will engage with investors at the South Florida Life Sciences Showcase and FII PRIORITY Miami, reinforcing its presence in the U.S. market. CEO Sébastien Plouffe emphasized the importance of building collaborations to support the growth of Accum® in the therapeutic field.

StockTitan

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

Proshares UltraShort Nasdaq Biotech

SPDR S&P Biotech

Ark Genomic Revolution ETF

Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March | DTCFF Stock News

SBIO

Defence Therapeutics Inc. held a Scientific Advisory Board meeting on January 30, 2026, to advance its Accum® ADC strategy. Experts discussed ADC chemistry, development, and clinical partnerships, refining the development roadmap for Accum® to enhance intracellular delivery of ADC payloads. The insights gained will inform future studies and align with clinical and pharmaceutical partner expectations. Defence aims to improve ADC therapies' effectiveness and tolerability, positioning Accum® as a next-generation solution in cancer treatment. For partnership inquiries, contact info@defencetherapeutics.com.

iShares US Pharma

ALPS Medical Breakthrough

Therapeutics MD

Turn Therapeutics

VG Health

iShares Global Healthcare

Health Care Select Sector SPDR

Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board | DTCFF Stock News

Solo has launched Solo Studio, a self-serve design platform for home energy contractors, enhancing their proposal management capabilities. This new tool allows contractors to create accurate, finance-ready proposals for solar, battery storage, roofing, and HVAC systems. The platform also features expanded capabilities for bundled proposals and improved financial integrations, enabling faster access to financing options. Additionally, Solo has secured two U.S. patents for its innovative proposal technology, further solidifying its position in the home energy market.

prnewswire

09:04 ET
			
			
				Solo Launches Solo Studio, Expands Platform Capabilities Across Home Energy Markets

In Thursday's pre-market session, ECD Automotive Design (NASDAQ:ECDA) saw a significant gain of 26.1%, reaching $0.59, while Solo Brands (NYSE:SBDS) rose 6.47% to $6.41. Other gainers included QVC Group (NASDAQ:QVCGA) up 4.78%, Lead Real Estate Co (NASDAQ:LRE) up 4.67%, and Kodiak AI (NASDAQ:KDK) up 4.37%. Conversely, Helen Of Troy (NASDAQ:HELE) fell 12.5% to $18.45, followed by Kandal M Venture (NASDAQ:FMFC) down 8.59%, and Park Ha Biological Tech (NASDAQ:BYAH) down 7.8%.

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

CPNG

CREV

CREVF

In Friday's pre-market session, Coupang, Carbon Revolution, Cango, Super X AI Technology, Solo Brands, and Barnes & Noble Education saw stock price increases, with Coupang leading at a 5.2% rise. Conversely, Mynd.ai, Kandal M Venture, Lobo Technologies, CCH Holdings, Neo-Concept International, and Ping An Biomedical experienced declines, with Mynd.ai dropping by 12.6%. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Coupang

Carbon Revolution

CARBON REVOLUTION PLC

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

During Monday's after-market session, INNEOVA Holdings rose 19% to $0.62, Solo Brands increased 6.13% to $7.44, and United Homes Gr gained 4.31% to $1.45. Meanwhile, Jinxin Technology Holding fell 4.7% to $0.63, Autozi Internet Tech decreased 3.62% to $3.2, and Super X AI Technology dropped 3.17% to $15.0.

United Homes

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

Solo Brands(DTC.US)